JOHN FOLH: Open Payments
NPI 1225102239 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,237 in 34 payments from 11 companies in 2025. Trend: 2023 $1,429 · 2024 $1,308 · 2025 $1,237
Food & beverage: $925Education: $312
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 6 | $319 |
| Astellas Pharma US Inc | 7 | $291 |
| Syndax Pharmaceuticals, Inc. | 6 | $192 |
| AstraZeneca Pharmaceuticals LP | 3 | $99 |
| Incyte Corporation | 3 | $88 |
| Lilly USA, LLC | 3 | $75 |
| Celgene Corporation | 2 | $55 |
| ABBVIE INC. | 1 | $33 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $29 |
Products named: Vonjo, Doptelet, CALQUENCE, Cresemba, JAKAFI, REBLOZYL, JAYPIRCA, Xospata.
Industry payments across TX — which companies pay providers there.
